Physician profile

Cheryl Hicks

Family · Rosiclare, IL

NPI 1588018188

$332.78

in general payments reported to CMS, 2019-2025

7 companies · $13.65 in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$45.90

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $84.28 2021-2025 Xifaxan
Sunovion Pharmaceuticals INC. $70.60 2021-2022
Dexcom, INC. $65.53 2021-2023 Dexcom G6 Transmitter
Glaxosmithkline, LLC. $58.98 2021
Xeris Pharmaceuticals, INC. $23.43 2022
Esperion Therapeutics, INC. $16.24 2021
Astrazeneca Pharmaceuticals LP $13.72 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Cheryl Hicks

$332.78

in general payments reported 2019-2025

Years
2021-2025
Top company
Salix Pharmaceuticals, A Division of Bausch Health US, LLC

https://glasscript.com/doctor/10604382/cheryl-hicks

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.